Fourth-Generation Cephalosporins: Dosage/Route: Adult & Pediatric: (>12 y); 200-400 mg PO b.i.d.; reduce dose with renal impairment Usual Indications: Treatment of acute exacerbations of chronic bronchitis; pharyngitis and tonsilitis; skin and skin-structure infections